ISOCURE BIOSCIENCES INC has a total of 22 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are JIKAI BIOSCIENCES INC, PIQUR THERAPEUTICS AG and MYOKARDIA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 3 | |
#3 | Canada | 3 | |
#4 | China | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Republic of Korea | 3 | |
#7 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Tinghu | 22 |
#2 | Che Jianwei | 22 |
Publication | Filing date | Title |
---|---|---|
EP3658563A1 | Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereof | |
CN110291085A | Saltant type isocitric dehydrogenase inhibitor, composition and its method | |
US2019233414A1 | Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereof |